Who we are
ImmPro was founded to put the power of proteoforms directly into the hands of clinicians and drug developers.
Through Individual Ion Mass Spectrometry (I2MS), we are able to go larger and deeper than ever before. Since our launch in 2024, we have been working with the best and brightest to leverage intact protein species in supercharging drug and disease research.
Check out the literature below, and reach out to hello@immpro.com to learn about how we can enable your unique application.
Drug characterization
Patient pre-screening
Patient and therapeutic monitoring
Contact us
Whether you are a potential customer, collaborator, or co-developer, we are excited to hear from you about how we can help your next project.